Xujia Yan
Changchun Institute of Biological Products(CN)National Institutes for Food and Drug Control(CN)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Animal Virus Infections Studies, COVID-19 Clinical Research Studies, Viral gastroenteritis research and epidemiology, Immunotherapy and Immune Responses
Most-Cited Works
- → Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine(2021)103 cited
- → Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates(2022)29 cited
- → Transcriptomic analysis of the innate immune signatures of a SARS-CoV-2 protein subunit vaccine ZF2001 and an mRNA vaccine RRV(2022)15 cited
- → Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitors(2023)15 cited
- → Mixed formulation of mRNA and protein‐based COVID‐19 vaccines triggered superior neutralizing antibody responses(2022)5 cited
- → Establishment of the first Chinese national standard for protein subunit SARS-CoV-2 vaccine(2022)4 cited
- → Construction and verification of an infectious cDNA clone of coxsackievirus B5(2022)4 cited
- → Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaques(2022)4 cited
- → Evaluation of the cross-neutralization activities elicited by Coxsackievirus A10 vaccine strains(2021)2 cited